ResMed Inc
(STU:RME)
€
238
-0.2 (-0.08%)
Market Cap: 33.56 Bil
Enterprise Value: 33.96 Bil
PE Ratio: 32.69
PB Ratio: 6.97
GF Score: 98/100 Resmed Inc at Bank of America Merrill Lynch Global Healthcare Conference Transcript
Sep 14, 2022 / 08:05AM GMT
Release Date Price:
€233.15
Lyanne Harrison
BofA Securities, Research Division - VP in Global Equity Research
Mick, thank you so much for coming to our conference.
Michael J. Farrell
ResMed Inc. - CEO & Director
Happy to be here, Lyanne. Thank you for hosting us.
Questions & Answers
Lyanne Harrison
BofA Securities, Research Division - VP in Global Equity Research
So it's been a very interesting few years for ResMed. And so why don't we start with, obviously, the COVID disruption and the likes there. What's -- obviously, some challenges because of COVID, but what's come out of COVID that's been a positive, both for ResMed and the industry?
Michael J. Farrell
ResMed Inc. - CEO & Director
I mean huge implications for the whole world through the COVID-19 pandemic and the recovery. I think for us, I mean, obviously, the challenges we face, the same challenges as everyone did, which is shut down, go fully remote for parts of the business that weren't manufacturing, tech service,
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot